Rheumatoid Arthritis Trial, Recruiting (NCT05760898)

Rheumatoid Arthritis Trial, Recruiting NCT05760898 Sponsor: Duke University Condition: Rheumatoid Arthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05760898 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rheumatoid Arthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have high blood pressure that is not well controlled
You have been diagnosed with rheumatoid arthritis
You receive both your general (primary) care and your rheumatology (joint/arthritis specialist) care through the Duke Health System

Who may not be able to join:

You are under 18 years old
You are a healthy volunteer who does not have rheumatoid arthritis or uncontrolled high blood pressure
You do not receive both your primary care and rheumatology care through the Duke Health System
You have a cognitive (memory or thinking) condition that would make it difficult to give your informed consent to take part in the study (confirm with trial site)
You are currently pregnant
You are currently incarcerated (in prison)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 919-613-2243

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05760898

Sponsor: Duke University

Phase: Not Applicable

Status: Recruiting

Condition: Rheumatoid Arthritis

Trial contact: 919-613-2243

More information: https://clinicaltrials.gov/study/NCT05760898

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have high blood pressure that is not well controlled
You have been diagnosed with rheumatoid arthritis
You receive both your general (primary) care and your rheumatology (joint/arthritis specialist) care through the Duke Health System

Who may not be able to join:

You are under 18 years old
You are a healthy volunteer who does not have rheumatoid arthritis or uncontrolled high blood pressure
You do not receive both your primary care and rheumatology care through the Duke Health System
You have a cognitive (memory or thinking) condition that would make it difficult to give your informed consent to take part in the study (confirm with trial site)
You are currently pregnant
You are currently incarcerated (in prison)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Duke University

Registry

ClinicalTrials.gov

Start date

16 January 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Intervention feasibility as measured by participant accrual rates; Intervention feasibility as measured by participant retention; Intervention feasibility as measured by adherence to blood pressure monitoring; Intervention feasibility as measured by adherence to survey reporting; Intervention feasibility as measured by sample characteristics; Intervention feasibility as measured by use of resources; Intervention feasibility as measured by sustainability of data collection procedures; Intervention acceptability as measured by qualitative interviews; Perceived appropriateness of the intervention...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov